Use of glucocorticoids in rheumatoid arthritis – Pratical modalities of glucocorticoid therapy: Recommendations for clinical practice based on data from the literature and expert opinion

Balancing benefits and risks of glucocorticoids in rheumatic diseases and other inflammatory joint disorders: new insights from emerging data. An expert consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)

“…Triamcinolone hexacetonide was the preferred choice in a recent review [142] based on clinical response. For the treatment of adhesive capsulitis a 20 mg dose of triamcinolone hexacetonide was recently been demonstrated to be non-inferior to a 40 mg dose, so it is possible that similar dose comparisons might prove valuable in RA [143].…”

Intra-articular glucocorticoid injections in patients with juvenile idiopathic arthritis in a Singapore hospital

“…(14) Generally, 24-hour postinjection rest is recommended. (16) Complications associated with IAG are uncommon and mainly localised. Of these, the most notable are cutaneous hypopigmentation and subcutaneous atrophy.…”

Management of Rheumatoid Arthritis: Consensus Recommendations From the Turkish League Against Rheumatism

“…Intraarticular steroids are recommended when disease activity is limited to one or a few joints. [145] Intraarticular corticosteroids have been associated with successful outcomes in cases of persistent monoarthritis in patients with RA. [145][146][147] It was reported in a systematic review that intraarticular steroids provided some beneficial effects with regard to knee pain, limitation of motion, walking distance, and morning stiffness.…”

“…[145] Intraarticular corticosteroids have been associated with successful outcomes in cases of persistent monoarthritis in patients with RA. [145][146][147] It was reported in a systematic review that intraarticular steroids provided some beneficial effects with regard to knee pain, limitation of motion, walking distance, and morning stiffness. [146] It has also been shown that triamcinolone hexacetonide is the most effective and longest-acting molecule among intraarticular steroids used in the knee joint.…”

“…For safety reasons, a maximum of three to four injections per year is recommended, and weight-bearing joints should be rested after the injection for at least 24 hours. [145] Studies have shown that intraarticular injection of steroids may lead to adverse events similar to systemic administration. [148] However, these adverse reactions are restricted and not long-lasting.…”